Cargando…

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

Chronic kidney disease (CKD) is one of the increasingly serious public health concerns worldwide; the global burden of CKD is increasingly due to high morbidity and mortality. At present, there are three key problems in the clinical treatment and management of CKD. First, the current diagnostic indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Zhonghong, Wang, Guanran, Shi, Xingyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724575/ https://www.ncbi.nlm.nih.gov/pubmed/34992536 http://dx.doi.org/10.3389/fphar.2021.785375

Ejemplares similares

The controversy of klotho as a potential biomarker in chronic kidney disease
por: Yu, Li-Xia, et al.
Publicado: (2022)

Effect of sodium bicarbonate on cardiovascular outcome and mortality in patients with advanced chronic kidney disease
por: Cheng, Ya-Lien, et al.
Publicado: (2023)

TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
por: Zixin, Ye, et al.
Publicado: (2022)

Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults
por: Zhang, Yuanyuan, et al.
Publicado: (2022)

Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics
por: Hewitson, Timothy D., et al.
Publicado: (2017)

Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation
por: Liu, Tao, et al.
Publicado: (2022)

Statin uses in adults with non-dialysis advanced chronic kidney disease: Focus on clinical outcomes of infectious and cardiovascular diseases
por: Hsiao, Ching-Chung, et al.
Publicado: (2022)

Neuropsychiatric Disorders in Chronic Kidney Disease
por: Simões e Silva, Ana Cristina, et al.
Publicado: (2019)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms
por: Wang, Yunlai, et al.
Publicado: (2022)

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
por: Yu, Wei, et al.
Publicado: (2022)

Intranasal dexmedetomidine improves postoperative sleep quality in older patients with chronic insomnia: a randomized double-blind controlled trial
por: Wu, Jinghan, et al.
Publicado: (2023)

The critical role of dysregulated autophagy in the progression of diabetic kidney disease
por: Zhang, Ziwei, et al.
Publicado: (2022)

Biomarker identification and pathway analysis of Astragalus membranaceus and Curcuma zedoaria couplet medicines on adenine-induced chronic kidney disease in rats based on metabolomics
por: Lu, Lingfei, et al.
Publicado: (2023)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
por: Li, Xiaohui, et al.
Publicado: (2022)

A New Definition of Pyroptosis-Related Gene Markers to Predict the Prognosis of Lung Adenocarcinoma
por: Zhang, Guanran, et al.
Publicado: (2021)

Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis
por: Puzzovio, Pier Giorgio, et al.
Publicado: (2021)

Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease
por: Zhao, Mingming, et al.
Publicado: (2021)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease
por: Li, Qing, et al.
Publicado: (2021)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

miRNAs as Novel Biomarkers of Chronic Kidney Injury in Anabolic-Androgenic Steroid Users: An Experimental Study
por: Sessa, Francesco, et al.
Publicado: (2020)

Assessment of Metabolomic and Proteomic Biomarkers in Detection and Prognosis of Progression of Renal Function in Chronic Kidney Disease
por: Nkuipou-Kenfack, Esther, et al.
Publicado: (2014)

NMI: a potential biomarker for tumor prognosis and immunotherapy
por: He, Teng, et al.
Publicado: (2022)

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
por: Liu, Ya-Fei, et al.
Publicado: (2023)

The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease
por: Shu, Huapan, et al.
Publicado: (2023)

Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients
por: Xiao, Yan-Zhuan, et al.
Publicado: (2021)

Editorial: Applications of Herbal Medicine to Control Chronic Kidney Disease
por: Chen, Jianping, et al.
Publicado: (2021)

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
por: Curran, Colleen S., et al.
Publicado: (2022)

Hypertension in chronic kidney disease: What lies behind the scene
por: Ameer, Omar Z.
Publicado: (2022)

Astragaloside IV alleviates 1-deoxysphinganine-induced mitochondrial dysfunction during the progression of chronic kidney disease through p62-Nrf2 antioxidant pathway
por: Gui, Ting, et al.
Publicado: (2023)

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
por: Yang, Letian, et al.
Publicado: (2022)

Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhang, Ming-Zhu, et al.
Publicado: (2022)

The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis
por: Wang, Lijun, et al.
Publicado: (2022)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats
por: Vacková, Šárka, et al.
Publicado: (2019)

New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease
por: Shao, Minghai, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Combination of Rhein and Curcumin in the Treatment of Chronic Kidney Disease in Rats
por: He, Xiaoying, et al.
Publicado: (2020)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

How to use COVID-19 antiviral drugs in patients with chronic kidney disease
por: Kale, Ajinath, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0pvl86a8tlgd3s90q5pq37bsu